Optimal antithrombotic therapy after transcatheter aortic valve replacement in patients with atrial fibrillation

• Main Authors: Qingchun Zeng (Author), Zhendong Cheng (Author), Yi Xia (Author), Rui Cheng (Author), Ailian Ou (Author), Xinrui Li (Author), Xingbo Xu (Author), Yuli Huang (Author), Dingli Xu (Author)
• Format: Book
• Published: SAGE Publishing, 2020-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Atrial fibrillation (AF) is prevalent in patients with aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR). Depending on the timing of AF detection, it is usually categorized as pre-existing AF or new-onset AF. Antiplatelet therapy, rather than a vitamin K antagonist, may b...